Federal Supply Schedule 36F79724D053E

Award Date 9/15/24
Last Date to Order 3/14/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Verona Pharma, Inc. for the provision of pharmaceutical, hematology, and related products. The Multiple Award contract has a ceiling value of $225,000.00 and a period of performance from March 15, 2025 through March 14, 2030. The contract is classified as 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under the Federal Supply Schedule. As a Federal Supply Schedule, this is an...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Valinor Pharma, LLC, a for-profit limited liability company. The contract is a multiple award, non-set-aside agreement with a ceiling value of $25,000.00 and a period of performance through October 17, 2023. The contract is an "Interim Agreement" issued under Federal Supply Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 (VISN 12) to Verrica Pharmaceuticals Inc., a pharmaceutical company that specializes in dermatology and hematology-related products. The $225,000 multiple-award contract under FSS Schedule 65 IB allows VA medical centers and other ordering activities to acquire Verrica's prescription medications, topical treatments, and other drug products through February...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Verity Pharmaceuticals, Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the FSS-61-IB schedule, with a contract ceiling value of $225,000.00 and a period of performance through November 30, 2026. The...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award contract,...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Springworks Therapeutics, Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through April 14, 2024. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows government agencies to procure these...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to provide drugs, pharmaceuticals, and hematology-related products to VHA facilities. The prime contractor is Nabriva Therapeutics US Inc., a for-profit organization. The contract has a potential value of $225,000 and a period of performance through October 15, 2023. No set-asides were used in the...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), is for the procurement of 65IB, Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Shorla Oncology Inc., a for-profit, foreign-owned organization. The contract has a ceiling value of $250,000.00 and a period of performance from August 15, 2024 to August 14, 2029. The contract aims to provide the VA with a range of pharmaceutical and hematology-related products. While no...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is a $200,000.00 interim agreement with Amarin Pharma, Inc. to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB. The contract has an ultimate completion date of August 30, 2024 and was awarded on March 5, 2024 without any set-aside requirements. The purpose of this multiple-award FSS contract is to...
  • 36F79724D053E
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

The provided information describes a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Verona Pharma, Inc. The contract, with an ID of 36F79724D053E, is for the procurement of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple-award contract with a period of performance through March 14, 2025 and a ceiling value of $25,000.00.

As a Federal Supply Schedule contract, this agreement establishes pre-negotiated prices, terms, and conditions for the government's purchase of the contractor's products and services. The contract was awarded on September 15, 2024 and does not utilize any set-asides. Verona Pharma, Inc. is a for-profit organization registered in SAM.gov, with an expiration date of December 20, 2024. This contract supports the VA's healthcare operations through the procurement of essential medical products, allowing the agency to efficiently obtain these items through an established IDV vehicle.

Generated 9/5/24, 9:10 AM